Camilla Vanni

Dr. Camilla Vanni

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2020 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
BMBeatrice Trabalza Marinucci
Beatrice Trabalza Marinucci
GMGiulio Maurizi
Giulio Maurizi
CVCamilla Vanni
Camilla Vanni
GCGIUSEPPE CARDILLO
GIUSEPPE CARDILLO
CPCamilla Poggi
Camilla Poggi
ERErino Angelo Rendina
Erino Angelo Rendina
OBJECTIVES: Few experiences comparing paediatric and adult patients treated for pulmonary sequestration (PS) have been reported. Surgical treatment is considered the best choice, but the time of surgery is still controversial. We present our experience in this setting, comparing characteristics, histological results and outcome of paediatric and adult patients undergoing PS resection. METHODS: Between 1998 and 2017, a total of 74 patients underwent lobectomy or sublobar resection for PS. Sixty patients were children (group A: ≤16 years old) and 14 were adults (group B: >16 years old). Preoperative diagnosis was radiological. PS was intralobar (42 cases) and extralobar (32 cases). The operation was a muscle-sparing lateral thoracotomy or video-assisted thoracoscopic surgery. Preoperative characteristics, histological results and short-/long-term results of the 2 groups were retrospectively analysed and compared. RESULTS: Thirty-seven percent of the patients in group A presented with respiratory symptoms and 79% in group B (P = 0.44). Most symptomatic patients were treated with a lobectomy. In group A, 2 patients (3%) had a malignant transformation of the lesion. Patients with a prenatal diagnosis treated after the age of 1 year became more symptomatic than those operated on before the age of 1 year (57% vs 23%; P = 0.08). No differences were found in postoperative complications. Long-term stable remission of respiratory symptoms was obtained in 91% of patients in group A and 100% in group B. Adulthood (P = 0.03) and the association with congenital cystic adenomatoid malformation (P = 0.03) were negative prognostic factors for the development of respiratory symptoms. CONCLUSIONS: Surgical treatment of PS is safe and feasible. Despite the small number of patients included, study results indicated that an early operation during childhood may prevent the subsequent development of respiratory symptoms. Surgical treatment is also recommended to prevent the rare transformation into malignancy.

14 February 2025 in Cancers
Verified
Journal Article
Open access
PDF file
BMBeatrice Trabalza Marinucci
Beatrice Trabalza Marinucci
MMMASSIMILIANO MANCINI
MASSIMILIANO MANCINI
ASAlessandra Siciliani
Alessandra Siciliani
FMFabiana Messa
Fabiana Messa
PGPiccioni Giorgia
Piccioni Giorgia
MIMohsen Ibrahim
Mohsen Ibrahim
Non-small-cell lung cancer (NSCLC) accounts for 80–85% of all lung cancers. Approximately 20% of patients with NSCLC are diagnosed with stage IIIA–IIIB disease, for which the optimal treatment remains unclear. Meta-analyses reveal that neoadjuvant/perioperative ICI–chemotherapy significantly improves pathological complete response (pCR), overall survival (OS), major pathological response (MPR), and R0 rate compared to standard neoadjuvant chemotherapy. Resectability is achieved when R0 resection can be performed after surgery. Radiographic downstaging often does not correspond to surgical downstaging. In fact, intra-operative fibrosis due to chemo-immunotherapy (synonymous with ICI–chemotherapy) can create adhesions and consequent difficult planes for dissection. Thus, pneumonectomy cannot be avoided. Even the suspicion of N2 after neoadjuvant treatment is considered a limitation of upfront surgery because of the risk of pneumonectomy. The aim of this review is to explore the literature on the technical strategies for surgical excision of NSCLC after chemo-immunotherapy, addressing even the most challenging scenarios.

15 January 2025 in Cancers
Verified
Journal Article
Open access
PDF file
CVCamilla Vanni
Camilla Vanni
ERErino Angelo Rendina
Erino Angelo Rendina
GMGiulio Maurizi
Giulio Maurizi
ADAntonio D’Andrilli
Antonio D’Andrilli
Tumors located at the tracheal bifurcation constitute a heterogeneous group of neoplasms whose treatment poses significant challenges due to their anatomical location, the requirement for radical resection, the need to restore local anatomy, and the necessity of maintaining adequate oxygenation throughout the entire procedure. Advances in airway reconstruction surgical techniques, anesthesia, and complementary therapies have progressively expanded indications for radical treatment of these neoplasms, resulting in significant improvements in both short- and long-term outcomes in recent years.

19 December 2020 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
GMGiulio Maurizi
Giulio Maurizi
ADAntonio D’andrilli
Antonio D’andrilli
CVCamilla Vanni
Camilla Vanni
ACAnna Maria Ciccone
Anna Maria Ciccone
MIMohsen Ibrahim
Mohsen Ibrahim
ERErino Angelo Rendina
Erino Angelo Rendina

28 October 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BMBeatrice Trabalza Marinucci
Beatrice Trabalza Marinucci
ASAlessandra Siciliani
Alessandra Siciliani
CAClaudio Andreetti
Claudio Andreetti
TTTiracorrendo Tiracorrendo
Tiracorrendo Tiracorrendo
FMFabiana Messa
Fabiana Messa
MIMohsen Ibrahim
Mohsen Ibrahim
Objectives: The choice of the best Video-Assisted Thoracic Surgery (VATS) surgical approach is still debated. Surgeons are often faced with the choice between innovation and self-confidence. The present study reports the experience of a high-volume single institute, comparing data of uni-portal, bi-portal and tri-portal VATS, to find out the safest and most effective mini-invasive approach, leading surgeon’s choice. Methods: Between 2015 and 2022, a total of 210 matched patients underwent VATS lobectomy for early-stage cancer, using uni-portal (fifth intercostal space), bi-portal (seventh space for optic and the fifth), and tri-portal (seventh and the fifth/four) access. Patients were matched for age, BPCO, smoke, comorbidities, lesions (size and staging) to obtain three homogenous groups (A: uni-portal; B: bi-portal; C: tri-portal). The surgeons had comparable expertise. Data were retrospectively collected from institutional database and analyzed. Results: No differences were detected considering time of surgery, length of hospital stay, complications, conversion rate, specific survival, and days of chest tube length of stay. Better results on chest tube removal were described in group A (mean 1.1 days) compared to B (mean 2.6 days) and C (mean 4.7 days); nevertheless, they not statistically significant (p = 0.106). Conclusions: No significant differences among the groups were described, except for the reduction in chest tube permanence in group A. This allows to hypothesize an enhanced recovery after surgery in this group but the different approaches in this series seem to guarantee comparable safety and effectiveness. Considering no superiority of one method above the others, the best suggested approach should be the one for which the surgeon feels more confident.